Corning To Build Pharma Glass Packaging Mfg Facility in North Carolina
Corning, a material-sciences company, has announced plans to build a high-volume pharmaceutical glass packaging manufacturing facility in Durham County, North Carolina to support production of Corning Valor Glass, a new glass packaging product.
In July 2017, Corning, announced an overall planned investment of $4 billion in pharmaceutical packaging with the introduction of Corning Valor Glass, an alkali aluminosilicate-based product for parenteral drug packaging. Adding capacity for Valor Glass in Durham is part of Corning’s first $500-million phase of investment for the product, which follows similar Corning investments in the development and manufacturing of Valor Glass in Big Flats and Erwin, New York. The company says the first $500-million phase of the investment will create 1,000 new US jobs as part of an overall planned investment of $4 billion and the creation of 4,000 new high-tech jobs.
The new facility will be constructed adjacent to a Corning Life Sciences manufacturing facility. The company anticipates that the new facility will be operational by year-end 2019.
Corning partnered with Merck & Co. and Pfizer, which provided insights on pharmaceutical formulation and manufacturing processes, in combination with Corning’s glass-science and precision-forming capabilities to develop a glass packaging solution for injectable drugs in vials and cartridges. The companies’ continued collaborations will focus on additional evaluations and the deployment of the new product.
The new pharmaceutical glass packaging product is meant to enhance the storage and delivery of drug formulations by providing chemical durability, strength, and damage resistance, according to information from Corning.